Event Online NowRegister Now
Host of Annual In-Person Emerging Medtech Summit
(recognized as the must-attend event by thought-leading strategics & VCs)
Welcome to Q1 2020 Medtech Start-Up Spotlight
A single integrated device, MouthLabTM and cloud-based proprietary mobile application that is used to create a unique ‘biosignature’, composed of multiple digital biomarkers that intelligently reflects an individual’s true health; we call it Aidar COVIDTM. Our transformative rapid health assessment device, MouthLab, a non-invasive, at home, rapid health assessment device measures 10+ vital health parameters, such as oral temperature (TEMP), blood pressure (BP), respiratory rate (RR), respiratory flow cycle morphology (RFM), pulse rate (PR), three-lead electrocardiography (ECG), functional oxygen saturation of arterial hemoglobin (SpO2), heart rate (HR), heart rate variability (HRV), spirometer (SPIRO) or lung functions (FEV1, FVC, FEV1/FVC, PEF) and voice in just 30 seconds.
BioSculpture Technology (aka BST)
Commercial stage medical device company developing a disruptive minimally invasive treatment of type 2 diabetes and obesity.
Surgical navigation system designed to reduce radiation exposure to patients and caregivers during endovascular procedures
Implantable, bioresorbable medical device to functionally regenerate a damaged esophagus
Founder & CEO
Surgical instrumentation that enable users to perform surgical tasks consistently in hard to reach locations
Grace Wellness Products
The Butterfly a cloud based IoT rehabilitation device
Chief Executive Officer
Ibex Medical Analytics
Ibex is pioneering AI-based cancer diagnostics in pathology. We use artificial intelligence to develop clinical-grade algorithms that detect cancer as accurately as a human pathologist. Our Galen™ Platform uses the algorithms to analyse images, detect and grade cancer in biopsies, helping pathologists reduce diagnostic error rates and enable a more efficient workflow. Galen is also powering the Ibex discovery engine for AI cancer markers.
CEO & Co-founder
Our flagship product, VAPCare, is a US FDA approved technology which provides fully automated, completely closed, removal of oral secretions in ventilated patients. In the Covid scenario, VAPCare protects caregivers from infection by automating the current manual process of suctioning highly infected oral secretions, and also saves nursing time through automation of a laborious process.
A digital health-medical device combination product to be used at home for secure opioid storage, safe disposal, and active control dispensing with designs to treat the underlying causes of addiction and offer harm reduction technologies.
Device to non-invasively detect and monitor blood borne diseases in vivo, without taking blood
Cofounder & Chairman
Developing a rapid hand disinfection system to reduce healthcare associated infections (HAIs) using its proprietary, patented thinSpray technology and antiseptic LVNX-001. There is an unmet need for a hand hygiene solution that takes no more than 3-5 seconds, leaves hands dry, facilitates hand health, is portable to optimize workflow around the patient, and is effective against the pathogen Clostridium difficile, a leading cause of HAIs in hospitals.
President & CSO
Wearable wireless vital signs monitoring solutions for medical and consumer applications
Chief Executive Officer
Game-based rehabilitation devices and exercises for patients with neurological, central nervous system, and musculoskeletal injuries such as stroke
Developing and commercializing our fully implantable continuous dialysis device - The Holly.
CEO & Co-Founder
Developing an optical-based, non-invasive, chemicals and ionizing radiation free, medical imaging technology to provide early diagnosis, screening, and monitoring of deep tissue pathological conditions.
Founder & CTO
Developing a robust, hands free, automatic and low cost Urine Output monitoring device for the ICU, assisting in AKI detection and prevention.
A mobile app controlled wearable device for the treatment of moderate to severe pain.
Cerebral embolic protection for transcatheter aortic valve replacement (TAVR), cardiovascular percutaneous interventions and surgical procedures
Vaporous hyperoxia therapy device for skin wounds, including diabetic foot ulcers
AI-powered platform for the diagnosis and analysis of brain aneurysms
CEO & Founder
Voxello develops pioneering technology providing severely impaired patients the ability to communicate with caregivers and family effectively. Voxello developed the noddle® and noddle-chat to reduce adverse events, achieve better outcomes, and improve patient satisfaction while returning a sizable ROI to the hospital. Using any voluntary gesture such as a tongue click or minimal movement such as a head nod, a patient can access the nurse call and the noddle-chat, which is a speech generation device to communicate.